262 related articles for article (PubMed ID: 38203502)
21. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
22. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
23. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.
Qu CK; Shi ZQ; Shen R; Tsai FY; Orkin SH; Feng GS
Mol Cell Biol; 1997 Sep; 17(9):5499-507. PubMed ID: 9271425
[TBL] [Abstract][Full Text] [Related]
24. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
25. Molecular cloning and characterization of a tyrosine phosphatase from Monosiga brevicollis.
Zhao BF; Zhao ZJ
Biochem Biophys Res Commun; 2014 Oct; 453(4):761-6. PubMed ID: 25445586
[TBL] [Abstract][Full Text] [Related]
26. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
[TBL] [Abstract][Full Text] [Related]
27. Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera.
Tenev T; Keilhack H; Tomic S; Stoyanov B; Stein-Gerlach M; Lammers R; Krivtsov AV; Ullrich A; Böhmer FD
J Biol Chem; 1997 Feb; 272(9):5966-73. PubMed ID: 9038217
[TBL] [Abstract][Full Text] [Related]
28. Osteosarcoma cell proliferation suppression via SHP-2-mediated inactivation of the JAK/STAT3 pathway by tubocapsenolide A.
Zhu D; Chen C; Liu X; Wang S; Zhu J; Zhang H; Kong L; Luo J
J Adv Res; 2021 Dec; 34():79-91. PubMed ID: 35024182
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Src homology 2-containing tyrosine phosphatase 1 during activation of human neutrophils. Role of protein kinase C.
Brumell JH; Chan CK; Butler J; Borregaard N; Siminovitch KA; Grinstein S; Downey GP
J Biol Chem; 1997 Jan; 272(2):875-82. PubMed ID: 8995376
[TBL] [Abstract][Full Text] [Related]
30. Strategy for Leukemia Treatment Targeting SHP-1,2 and SHIP.
Hao F; Wang C; Sholy C; Cao M; Kang X
Front Cell Dev Biol; 2021; 9():730400. PubMed ID: 34490276
[TBL] [Abstract][Full Text] [Related]
31. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells.
Mizuno K; Katagiri T; Hasegawa K; Ogimoto M; Yakura H
J Exp Med; 1996 Aug; 184(2):457-63. PubMed ID: 8760799
[TBL] [Abstract][Full Text] [Related]
33. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1.
Burshtyn DN; Yang W; Yi T; Long EO
J Biol Chem; 1997 May; 272(20):13066-72. PubMed ID: 9148918
[TBL] [Abstract][Full Text] [Related]
34. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
[TBL] [Abstract][Full Text] [Related]
35. Positive effects of SH2 domain-containing tyrosine phosphatase SHP-1 on epidermal growth factor- and interferon-gamma-stimulated activation of STAT transcription factors in HeLa cells.
You M; Zhao Z
J Biol Chem; 1997 Sep; 272(37):23376-81. PubMed ID: 9287352
[TBL] [Abstract][Full Text] [Related]
36. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
[TBL] [Abstract][Full Text] [Related]
37. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells. Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2.
Tang H; Zhao ZJ; Landon EJ; Inagami T
J Biol Chem; 2000 Mar; 275(12):8389-96. PubMed ID: 10722671
[TBL] [Abstract][Full Text] [Related]
38. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia.
Kim HY; Park EJ; Joe EH; Jou I
J Immunol; 2003 Dec; 171(11):6072-9. PubMed ID: 14634121
[TBL] [Abstract][Full Text] [Related]
39. Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.
Huang TT; Su JC; Liu CY; Shiau CW; Chen KF
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594363
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic studies on full length and the catalytic domain of the tandem SH2 domain-containing protein tyrosine phosphatase: analysis of phosphoenzyme levels and Vmax stimulatory effects of glycerol and of a phosphotyrosyl peptide ligand.
Wang J; Walsh CT
Biochemistry; 1997 Mar; 36(10):2993-9. PubMed ID: 9062130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
